Get started
BIOCON LTD.BIOCON LTD.BIOCON LTD.

BIOCON LTD.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

BIOCON chart


Full chart

BIOCON upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪506.01 B‬ INR
Dividend yield (indicated)
0.13%
Price to earnings Ratio (TTM)
44.95
Basic EPS (TTM)
8.45 INR
Net income (FY)
‪10.13 B‬ INR
Revenue (FY)
‪152.11 B‬ INR
Shares float
‪510.58 M‬
Beta (1Y)
1.04

About BIOCON LIMITED.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Siddharth Mittal
Website
biocon.com
Headquarters
Bangalore
Founded
1978
ISIN
INE376G01013
FIGI
BBG000BJHBC9
Biocon Ltd. is a holding company, which engages in the manufacture, research, and development of therapeutic drugs. It operates through the following segments: Small Molecules, Biologics, Branded Formulations, and Research Services. The Small Molecules segment manufactures spanning statins, immunosuppressants, antifungals, anti-obesity, anti-diabetics, ophthalmologicals, oncologicals, and urologicals etc. The Biologics segment provides Insulins and Analogs, biosimilar Monoclonal Antibodies (MAbs), and recombinant proteins The Branded Formulation segment consists of therapeutic areas of diabetology, oncology, immunology and critical care. The Research Services segment covers Syngene development platforms. The company was founded by Kiran Mazumdar-Shaw on November 29, 1978 and is headquartered in Bangalore, India.

Check out other big names from the same industry as BIOCON.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BIOCON news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BIOCON is 390.20 INR — it has increased by 1.50% in the past 24 hours. Watch BIOCON LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange BIOCON LTD. stocks are traded under the ticker BIOCON.
BIOCON stock has fallen by −0.47% compared to the previous week, the month change is a 9.83% rise, over the last year BIOCON LTD. has showed a 11.97% increase.
We've gathered analysts' opinions on BIOCON LTD. future price: according to them, BIOCON price has a max estimate of 447.00 INR and a min estimate of 270.00 INR. Watch BIOCON chart and read a more detailed BIOCON LTD. stock forecast: see what analysts think of BIOCON LTD. and suggest that you do with its stocks.
BIOCON reached its all-time high on Dec 23, 2020 with the price of 487.70 INR, and its all-time low was 14.40 INR and was reached on Nov 28, 2008. View more price dynamics on BIOCON chart.
See other stocks reaching their highest and lowest prices.
BIOCON stock is 3.23% volatile and has beta coefficient of 1.04. Track BIOCON LTD. stock price on the chart and check out the list of the most volatile stocks — is BIOCON LTD. there?
Today BIOCON LTD. has the market capitalization of ‪506.01 B‬, it has increased by 0.15% over the last week.
Yes, you can track BIOCON LTD. financials in yearly and quarterly reports right on TradingView.
BIOCON LTD. is going to release the next earnings report on Aug 7, 2025. Keep track of upcoming events with our Earnings Calendar.
BIOCON earnings for the last quarter are 2.81 INR per share, whereas the estimation was 1.39 INR resulting in a 102.25% surprise. The estimated earnings for the next quarter are 0.71 INR per share. See more details about BIOCON LTD. earnings.
BIOCON LTD. revenue for the last quarter amounts to ‪44.17 B‬ INR, despite the estimated figure of ‪40.99 B‬ INR. In the next quarter, revenue is expected to reach ‪39.88 B‬ INR.
BIOCON net income for the last quarter is ‪3.44 B‬ INR, while the quarter before that showed ‪251.00 M‬ INR of net income which accounts for ‪1.27 K‬% change. Track more BIOCON LTD. financial stats to get the full picture.
Yes, BIOCON dividends are paid annually. The last dividend per share was 0.50 INR. As of today, Dividend Yield (TTM)% is 0.13%. Tracking BIOCON LTD. dividends might help you take more informed decisions.
BIOCON LTD. dividend yield was 0.15% in 2024, and payout ratio reached 5.91%. The year before the numbers were 0.19% and 5.85% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOCON LTD. EBITDA is ‪31.36 B‬ INR, and current EBITDA margin is 21.93%. See more stats in BIOCON LTD. financial statements.
Like other stocks, BIOCON shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOCON LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOCON LTD. technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOCON LTD. stock shows the strong buy signal. See more of BIOCON LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.